Efficacy Study of Korean Red Ginseng to Treat Depression
Efficacy Study of Korean Red Ginseng to Treat Depression
The purpose of this study is to determine whether Korean Red Ginseng are effective in the
 treatment of the residual symptoms of depression as an adjuvant treatment.
Thirty-five female outpatients aging from 18 to 65 years, who were remitted from major
 depression with residual symptoms (Montgomery Asberg Depression Rating Scale, MADRS ≤ 12),
 were given Korean red ginseng at doses of 3g / day during 8 weeks.
Inclusion Criteria:

 -  Outpatients who met Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
 criteria for major depressive disorder.

 -  Those who are in remission, which is defined as a MADRS score 8 on two consecutive
 visits at a 4-week interval.

 -  Their primary psychiatric clinician determined that they would benefit from an
 adjuvant treatment of Korean red ginseng for residual symptoms.

 Exclusion Criteria:

 -  Those who have a history of substance abuse or dependence within 1 month.

 -  Those who have clinically significant abnormal laboratory values or any other abnormal
 baseline laboratory findings considered by psychiatrists to be indicative of
 conditions that might affect the study results.

 -  Those who have a past history of hypersensitivity or intolerance to Korean red
 ginseng.

 -  Those who participated in clinical trials within 1 month before entering the study
 entry.

 -  Those who are pregnant or are breast feeding.

 -  Those who have a immediate risk of harming self or others or history of suicide
 attempts in the year before the screening precluded inclusion in the study.

 -  The patients unable/unlikely to comprehend/follow the protocol.